| Entry |
|
|---|
| Name |
Tarcocimab tedromer (INN) |
|---|
| Formula |
C36322H69510N4422O18267S44P2699Br9
|
|---|
| Exact mass |
945733.8351
|
|---|
| Mol weight |
946241.4016
|
|---|
| Efficacy |
Angiogenesis inhibitor |
|---|
| Type |
Antibody-drug conjugate |
|---|
| Comment |
Antibody-biopolymer conjugate
Treatment of vascular diseases, especially macular degeneration and diabetic retinopathy
|
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Brite |
Target-based classification of drugs [BR:br08310]
Cytokines and receptors
Cytokines
Growth factors (RTK-binding)
VEGFA
D12508 Tarcocimab tedromer (INN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
